Lexi-Comp's transactional drug data and reference information supports various components of Stage 1 meaningful use and certification criteria from ONC's Final Rule, specifically the implementaiton of electronic clinical decision support rules (drug-to-drug and drug allergy contraindication checking) based on the data elements included in: problem list, medication list, demographics and laboratory test results.
Lexi-Data, Lexicomp's clinical decision support database, will help you meet several aspects of clinical decision support required for certification. Here's how:
Drug Interaction Data - we'll provide your system data that enables clinicians to screen for drug interactions, including drug-allergy, drug-drug and drug-food
RxNorm Mapping - we promote interoperability through mapping to industry standard RxNorm
Drug Reference Data - integrate drug reference information, such as drug images and black box warnings, into your system
Patient Education Data - we provide patient education information that allows users to generate patient-specific handouts for medications (available in 19 languages), and conditions and procedures (available in English and Spanish)
Dose Range Checking - we provide data that enables clinicians to receive dosing alerts for medications, including limits for pediatric patients
Lexi-Data is designed for easy implementation. Our intuitive database design will help you seamlessly integrate complex drug databases into your system.
Powered by Compendium
Comments for Standard Ambulatory EHR Criteria